Anti-GARP CAR-T Cell Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-GARP CAR-T Cell Therapy, covering 2025-10-29 to 2025-10-29. Get the full timeline:
Most recent: Clinical Trial Update: Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas [Phase 1]